Phase III Noninferiority Trial Comparing Irinotecan With Oxaliplatin, Fluorouracil, and Leucovorin in Patients With Advanced Colorectal Carcinoma Previously Treated With Fluorouracil: N9841

PURPOSE: The primary goal of this multicenter phase III trial was to determine whether overall survival (OS) of fluorouracil (FU) -refractory patients was noninferior when treated with second-line infusional fluorouracil, leucovorin, and oxaliplatin (FOLFOX4; arm B) versus irinotecan (arm A). Cross-...

Full beskrivning

Sparad:
Bibliografiska uppgifter
Huvudupphovsmän: Kim, George P., Sargent, Daniel J., Mahoney, Michelle R., Rowland, Kendrith M., Philip, Philip A., Mitchell, Edith, Mathews, Abraham P., Fitch, Tom R., Goldberg, Richard M., Alberts, Steven R., Pitot, Henry C.
Materialtyp: Artigo
Språk:Inglês
Publicerad: American Society of Clinical Oncology 2009
Ämnen:
Original Reports
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC2698019/
https://ncbi.nlm.nih.gov/pubmed/19380443
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2008.20.4552
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk